oral

Palbociclib improves progression-free survival in HER2 positive breast cancer

by

Palbociclib Breakthrough: A New Era for HER2-Positive Breast Cancer Treatment? Recent findings published in the New England Journal of Medicine are generating significant excitement in the breast cancer community. The PATINA study demonstrates that adding palbociclib to standard treatment for hormone receptor-positive (HR+), HER2-positive metastatic breast cancer can substantially prolong progression-free survival (PFS). This represents … Read more

New breakthrough could modernize treatment for glioblastoma

by

A New Dawn for Glioblastoma Treatment: Combining Chemotherapy with a Surprising Ally For decades, glioblastoma, one of the most aggressive forms of brain cancer, has stubbornly resisted effective treatment. Survival rates remain grim – around 7% beyond five years post-diagnosis. But a groundbreaking study from the UNC School of Medicine and UNC Eshelman School of … Read more

Understanding how the immune system protects against fungal pathogenicity

by

Why Candida albicans Matters Beyond the Mouth The yeast Candida albicans lives on our oral and gut mucosa as a quiet roommate. When the balance tilts, it can turn into a lethal pathogen, causing oral thrush, bloodstream infections and, according to the World Health Organization, more than one million deaths each year. Future Trend #1 … Read more

New Coronavirus Discovery in Brazilian Bats: Scientist Unveils Novel Strain – What You Need to Know

by

The Emerging Threat: A New Coronavirus from Brazil Recently, scientists have unveiled a new coronavirus found in bats in Brazil, sharing a significant genetic resemblance to the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). While its capability to infect humans remains uncertain, this discovery prompts a closer look at viral evolution and potential public health implications. … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]